About Starlight Therapeutics
Starlight Therapeutics is a Healthcare company based in Plano (United States) founded in 2023. It develops AI-driven drugs for brain and CNS cancers through research and clinical trials. It operates on a B2B model. Starlight Therapeutics offers products and services including STAR-001. Its focus areas include Biotech, Oncology, CNS Cancers and Pediatric CNS Cancers. Its legal entity is Starlight Therapeutics Inc. Its competitors include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Starlight Therapeutics is a precision oncology company specializing in central nervous system cancers, using AI to analyze billions of data points and collaborate with global researchers. It develops innovative therapies like STAR-001, targeting brain tumors such as glioblastoma and metastases, with a focus on adult and pediatric cases. The company conducts clinical trials for underserved indications, emphasizing blood-brain barrier permeability and nanomolar potency. Headquartered in Plano, Texas, it aims to address gaps in current treatments like surgery, radiotherapy, and chemotherapy.
- Headquarters Plano, United States
- SectorsHealthcare
- Email••••••••
- Website starlightthera.com
- Social LinkedIn
- Legal Name Starlight Therapeutics Inc.
Products & Services of Starlight Therapeutics
Starlight Therapeutics offers a comprehensive portfolio of products and services, including STAR-001.
AI-powered treatment for CNS cancers with high potency.
Competitors of Starlight Therapeutics
Starlight Therapeutics has 7 listed competitors in our database, 6 of them funded. They include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| faunabio.com | 2018 | Berkeley, United States | $13.1M | 19 | Animal genomics is applied to healthcare advancements by Fauna Bio. | |
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| lila.ai | 2023 | – | $550M | – | AI-powered platforms for autonomous scientific research are developed. | |
| humaneva.com | 2014 | Raleigh, United States | $50M | – | Provider of clinical research data services for oncology & other therapeutic areas | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. | |
| rgnmed.com | 2014 | Greenwich, United States | $290,000 | – | Healthcare data analytics company that enables clinical and financial value creation for clinicians |
Detailed competitors of Starlight Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
10 companies that operate in the same segment as Starlight Therapeutics (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Starlight Therapeutics
Starlight Therapeutics was founded in 2023.
Starlight Therapeutics is headquartered in Plano, United States. It is registered at Plano, Texas, United States.
Starlight Therapeutics is a precision oncology company specializing in central nervous system cancers, using AI to analyze billions of data points and collaborate with global researchers. It develops innovative therapies like STAR-001, targeting brain tumors such as glioblastoma and metastases, with a focus on adult and pediatric cases. The company conducts clinical trials for underserved indications, emphasizing blood-brain barrier permeability and nanomolar potency. Headquartered in Plano, Texas, it aims to address gaps in current treatments like surgery, radiotherapy, and chemotherapy.
Starlight Therapeutics's top competitors include Fauna Bio, Predxbio and Lila Sciences.
Starlight Therapeutics offers STAR-001.
Starlight Therapeutics operates through Starlight Therapeutics Inc..